Interní Med. 2005; 7(6): 291-295
Newest advances in therapy of COPD
- privátní plicní a praktický lékař, Neratovice
Chronic obstructive pulmonary disease (COPD) affects about 6–10% of the global population and is a cause of substantial morbidity, mortality and cost of society. Although much has been written about COPD as a disease, less is known about how patients experience their bad illness. Physicians should be aware of these feelings and take care not to exacerbate the patients´ distress by assuming that little can be done help. Because the hopeless associated with COPD is no longer apppropriate. There are effective interventions, and much be done to improve patients´ health status and emotional status. It is important, however, that both patients and physicians approach the disease with a positive attitude.
Keywords: Key words: COPD, spirometry, exacerbation of COPD, inhalation therapy.
Published: January 1, 2006 Show citation
References
- Calverley PM, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur. Respir. J., 2003; 22: 912-919.
Go to original source... 
Go to PubMed... - European Respiratory Journal, Abstracts, 14th ERS Annual Congressus Glasgow, UK, 4-8th 2004: 816 s.
- Global Iniciative for Chronic Obstructive Lung Disease,Global Strategy for the Diagnosis, Management and Prevention of COPD. Vydané r. 2003,100 s. Ed. National Institute of Health.
- Russel R. Doporučení BTS/NICE 2004, Update, 6/2004; ročník 5: 36-37.
- Světová iniciativa o chronické obstrukční plicní nemoci, český překlad, České občanské sdružení proti CHOPN, vyd. Vltavín, Praha 2001: 208 s.
- Vondra V, Musil J, Kos S, Králíková E. Chronická obstrukční plicní nemoc. Vyd. Vltavín, Praha 2003: 64 s.